Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency
Clinical trial NCT03309891 · COMPLETED
Trial details
- NCT number
- NCT03309891
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-18
- Primary completion
- 2017-10-27
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.